Hurdles for innovative drug development at small biotech companies episode artwork

EPISODE · May 28, 2021 · 27 MIN

Hurdles for innovative drug development at small biotech companies

from White House Chronicle · host Llewellyn King

Llewellyn King discusses the hurdles for innovative drug development at small biotech companies with Linda Marbán, CEO of Capricor Therapeutics and Angelos Stergiou, MD, President and CEO, STELLAS Life Sciences Group, Inc.

Episode metadata supplied by the publisher feed · Published May 28, 2021

Embed this episode

NOW PLAYING

Hurdles for innovative drug development at small biotech companies

0:00 27:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of White House Chronicle?

This episode is 27 minutes long.

When was this White House Chronicle episode published?

This episode was published on May 28, 2021.

Can I download this White House Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!